Global Vascular Access Systems Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Product (Peripherally Inserted Central Catheter, Non-Tunneled Central Catheter, Tunneled Catheter, Port Catheter), By Application (Intravenous Antibiotic Treatment, Blood Transfusion, Long-Term IV Feeding, Chemotherapy, Others), By End User (Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Labs), And By Geography - Forecasts From 2021 To 2026

Published:  Jul 2021 Report Code: KSI061610470 Pages: 122

The global vascular access systems market is evaluated at US$ 4.744 billion for the year 2019 growing at a CAGR of 6.27% reaching the market size of US$ 7.259 billion by the year 2026.

Venous or arterial access is obtained through vascular access systems. Vascular Access Devices are medical equipment used to get ingress the bloodstream to supply medicines, administer fluids, nutritional components, and collection of blood vessels and their products. These vascular access tubes are made from latex, silicon, and other substances. The procedure involves placing rigid plastic tubes into blood vessels such as the basilic vein and subclavian vein to perform diagnostic tests and treatments such as chemotherapy, intravenous antibiotic treatment, and intravenous feeding. It includes blood sampling, blood transfusion, fluid infusion, and central venous pressure readings. The vascular access catheter devices are also significantly used in the case of chemotherapies.

The blood is obtained from or delivered to a person’s bloodstream over a continuous period through different vascular access devices such as cannulae, catheters, peripherals, and ports. The procedure relieves patients from the continuous stress of needles and offers a painless method to draw blood or provide medication. The rising global prevalence of diseases such as kidney failure, diabetes, and cancer which involve the transfer of blood to and from the human body is positively impacting the demand for vascular access systems. High infection risk associated with vascular access devices and stringent government approval regulations restrains the growth of the vascular access systems market.

The prevalence of diabetes, increasing rates of road accidents, and an increasing number of surgical procedures are expected to drive the market. Increasing demand for advanced techniques, such as needleless administration of drugs is also a vital driver for this market. Every day many healthcare workers handle drugs in hospitals and other healthcare centers. Despite precaution measures availability, there remains a risk of exposure to these drugs during procedures. Such exposures may occur through, ingestion, absorption, accidental inhalation, or dermal contact of a minimal amount of these drugs which may lead to a variety of health problems.

The advent of COVID-19 had a positive impact on the market of vascular access systems as it became an integral part of the treatment procedures that were followed during the period to cure the patients. Moreover, WHO declared COVID-19 a pandemic as the increase in the number of cases was exponential in the initial months. The medical authorities advised the hospitals and other such medical institutions to stock up the requirements to never run out of supplies during the treatments, which in turn, increased the demand for vascular access systems in the year 2020.

Innovations in the sector have brought down the costs of these products in recent years and the trend is expected to continue during the forecast period.

Global Vascular Access Systems Market Scope:

Report Metric Details
 Market size value in 2019  US$4.744 billion
 Market size value in 2026  US$7.259 billion
 Growth Rate  CAGR of 6.27% from 2019 to 2026
 Base year  2019
 Forecast period  2021–2026
 Forecast Unit (Value)  USD Billion
 Segments covered  Product, Application, End-User, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered  Edwards Lifesciences Corporation, Baxter International Inc., C.R. Bard, Inc.,   Fresenius  Medical Care AG & Co. KGaA, Becton, Dickinson and Company, Teleflex   Incorporated, Medtronic PLC, B.Braun Melsungen AG, Smiths Medical, Biomerics
 Customization scope  Free report customization with purchase

Segmentation

  • By Product
    • Peripherally Inserted Central Catheter (PICC)
    • Non-Tunneled Central Catheter
    • Tunneled Catheter
    • Port Catheter
  • By Application
    • Intravenous Antibiotic Treatment
    • Blood Transfusion
    • Long-Term IV Feeding
    • Chemotherapy
    • Others
  • By End-user
    • Hospitals and Clinics
    • Ambulatory Surgical Centers
    • Catheterization Labs
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • UK
      • Others
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

Q1. What are the growth prospects for the vascular access systems market?
A1. The global vascular access systems market is projected to grow at a CAGR of 6.27% over the forecast period.


Q2. What will be vascular access systems market size by 2026?
A2. The vascular access systems market is projected to reach a total market size of US$7.259 billion by 2026.


Q3. What is the size of the global vascular access systems market?
A3. Vascular Access Systems market was valued at US$4.744 billion in 2019. 


Q4. Who are the major players in the vascular access systems market?
A4. Major industry players profiled as part of the vascular access systems market report are Edwards Lifesciences Corporation, Baxter International Inc., C.R. Bard, Inc., Fresenius Medical Care AG & Co. KGaA, Becton, Dickinson and Company, Teleflex Incorporated among others.


Q5. What factors are anticipated to drive the vascular access systems market growth?
A5. The rising global prevalence of diseases such as kidney failure, diabetes, and cancer which involve the transfer of blood to and from a human body is positively impacting the demand for vascular access systems.

 

1. Introduction
1.1. Market Definition
1.2. Market Segmentation


2. Research Methodology
2.1. Research Data
2.2. Assumptions


3. Executive Summary
3.1. Research Highlights


4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis


5. Vascular Access Systems Market Analysis, by Product    
5.1. Introduction
5.2. Peripherally Inserted Central Catheter (PICC)
5.3. Non-Tunneled Central Catheter
5.4. Tunneled Catheter
5.5. Port Catheter


6. Vascular Access Systems Market Analysis, by Application    
6.1. Introduction
6.2. Intravenous Antibiotic Treatment
6.3. Blood Transfusion
6.4. Long-Term IV Feeding
6.5. Chemotherapy
6.6. Others


7. Vascular Access Systems Market Analysis, by End-user    
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Ambulatory Surgical Centers
7.4. Catheterization Labs


8. Vascular Access Systems Market Analysis, by Geography
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. UK
8.4.4. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others


9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix


10. Company Profiles 
10.1. Edwards Lifesciences Corporation
10.2. Baxter International Inc.
10.3. C.R. Bard, Inc.
10.4. Fresenius Medical Care AG & Co. KGaA
10.5. Becton, Dickinson and Company
10.6. Teleflex Incorporated
10.7. Medtronic PLC
10.8. B.Braun Melsungen AG
10.9. Smiths Medical
10.10. Biomerics

Edwards Lifesciences Corporation

Baxter International Inc.

C.R. Bard, Inc.

Fresenius Medical Care AG & Co. KGaA

Becton, Dickinson and Company

Teleflex Incorporated

Medtronic PLC

B.Braun Melsungen AG

Smiths Medical

Biomerics

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us